Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reductions in systolic blood pressure achieved by hypertensives with three isometric training sessions per week are maintained with a single session per week.
Cohen DD, Aroca-Martinez G, Carreño-Robayo J, Castañeda-Hernández A, Herazo-Beltran Y, Camacho PA, Otero J, Martinez-Bello D, Lopez-Lopez JP, Lopez-Jaramillo P. Cohen DD, et al. J Clin Hypertens (Greenwich). 2023 Apr;25(4):380-387. doi: 10.1111/jch.14621. Epub 2023 Mar 25. J Clin Hypertens (Greenwich). 2023. PMID: 36965163 Free PMC article. Clinical Trial.
Cell Signaling in Neuronal Stem Cells.
Navarro Quiroz E, Navarro Quiroz R, Ahmad M, Gomez Escorcia L, Villarreal JL, Fernandez Ponce C, Aroca Martinez G. Navarro Quiroz E, et al. Cells. 2018 Jul 14;7(7):75. doi: 10.3390/cells7070075. Cells. 2018. PMID: 30011912 Free PMC article. Review.
Optimizing dialysis dose in the context of frailty: an exploratory study.
Hernandez-Agudelo SY, Musso CG, González-Torres HJ, Castro-Hernández C, Maya-Altamiranda LP, Quintero-Cruz MV, Corradino C, Terrasa SA, Aroca-Martínez GJ, Cadena-Bonfanti A. Hernandez-Agudelo SY, et al. Int Urol Nephrol. 2021 May;53(5):1025-1031. doi: 10.1007/s11255-020-02757-8. Epub 2021 Jan 30. Int Urol Nephrol. 2021. PMID: 33515350
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial Investigators.
Monterroso VH, Rodriguez Chavez V, Carbajal ET, Vogel DR, Aroca Martinez GJ, Garcia LH, Cuevas JH, Lara Teran J, Hitzenberger G, Leao Neves P, Middlemost SJ, Dumortier T, Bunt AM, Smith RD. Monterroso VH, et al. Adv Ther. 2000 Mar-Apr;17(2):117-31. doi: 10.1007/BF02854844. Adv Ther. 2000. PMID: 11010055 Clinical Trial.
Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
Navarro-Quiroz E, Pacheco-Lugo L, Navarro-Quiroz R, Lorenzi H, España-Puccini P, Díaz-Olmos Y, Almendrales L, Olave V, Gonzalez-Torres H, Diaz-Perez A, Dominguez A, Iglesias A, García R, Aroca-Martinez G. Navarro-Quiroz E, et al. PLoS One. 2017 Nov 14;12(11):e0187973. doi: 10.1371/journal.pone.0187973. eCollection 2017. PLoS One. 2017. PMID: 29136041 Free PMC article.
Atypical hemolytic uremic syndrome in the Colombian Caribbean: its particular characteristics.
Cabarcas-Barbosa O, Aroca-Martínez G, Musso CG, Ramos-Bolaños E, González-Tórres H, Espitaleta-Vergara Z, Domínguez-Vargas A, Ararat-Rodriguez E, Orozco J, Castillo-Parodi L, Conde-Manotas J, Daza-Arnedo R, Rodríguez-SanJuan V, Gómez-Navarro L, Acosta-Madiedo R, Barros-Camargo L, Aduen-Carrillo A, Ayola-Anaya F, Pulgar-Emiliani M, Cadena-Bonfanti A. Cabarcas-Barbosa O, et al. Int Urol Nephrol. 2022 Jun;54(6):1323-1330. doi: 10.1007/s11255-021-03011-5. Epub 2021 Oct 13. Int Urol Nephrol. 2022. PMID: 34643860 Free PMC article.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
50 results